NASDAQ · AVR

Anteris Technologies Global Corp.

$8.13 -$0.06 (-0.73%) 1D After hours

Key Metrics

$797.23M
Market cap
P/E · TTM
$1.85M
Revenue · TTM
−$95.30M
Net income
EPS · TTM $-2.65
Dividend yield
Free cash flow −$86.84M
Beta · 1Y 1.58
EBITDA · TTM −$93.01M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 20
    The stock moved +11.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 20
  • May 14
    The stock moved +11.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 14

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$797.23M
Enterprise value
Shares outstanding97.3M
52-wk range$2.99 – $11.06
Avg volume · 20D558.1K
Net cash
Book value / share$7.73
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies
ExchangeNASDAQ
About Anteris Technologies Global Corp.
IPO dateDec 13, 2024
Employees174

Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S430.70
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating -5,116.2%
Net -5,148.8%
FCF -4,691.4%
ROE / ROIC -34.2% · —

Financial Health

Current ratio20.93
Quick ratio20.93
Debt / equity0.00
Debt / EBITDA -0.01
Net cash
Working capital$272.98M

Cash Flow · TTM

Operating CF −$84.99M
Capex −$1.84M
Free cash flow −$86.84M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

27.5
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings